In the present study, we demonstrated a possible metabolic compensation mechanism for IDH1-mutated glioma by elevating mTORC2 and small GTPase activity, which reorganized cytoskeleton and plasma membrane, and facilitated substance uptake via enhanced endocytosis. This evidence concerns the gene IDH1 and central nervous system cancer.